Nuveen’s Viridian Therapeutics VRDN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$11.8M Sell
604,914
-137,423
-19% -$4.08M ﹤0.01% 1455
2025
Q4
$23.1M Buy
742,337
+580,469
+359% +$15.9M 0.01% 1065
2025
Q3
$3.49M Sell
161,868
-61,367
-27% -$1.11M ﹤0.01% 2079
2025
Q2
$3.12M Sell
223,235
-25,393
-10% -$345K ﹤0.01% 2102
2025
Q1
$3.35M Sell
248,628
-432,384
-63% -$7.36M ﹤0.01% 2121
2024
Q4
$13.1M Buy
681,012
+452,627
+198% +$9.84M ﹤0.01% 1453
2024
Q3
$5.2M Sell
228,385
-270,018
-54% -$4.41M ﹤0.01% 1969
2024
Q2
$6.48M Sell
498,403
-834,051
-63% -$11.5M ﹤0.01% 1817
2024
Q1
$23.3M Buy
1,332,454
+1,098,574
+470% +$21.3M 0.01% 1083
2023
Q4
$5.09M Buy
233,880
+30,439
+15% +$481K ﹤0.01% 1969
2023
Q3
$3.12M Sell
203,441
-222,754
-52% -$4.25M ﹤0.01% 2104
2023
Q2
$10.1M Sell
426,195
-151,432
-26% -$3.88M ﹤0.01% 1502
2023
Q1
$14.7M Buy
577,627
+256,161
+80% +$8.21M 0.01% 1238
2022
Q4
$10.9M Buy
321,466
+218,717
+213% +$5.04M ﹤0.01% 1431
2022
Q3
$2.05M Buy
102,749
+43,834
+74% +$788K ﹤0.01% 2393
2022
Q2
$681K Buy
+58,915
New +$792K ﹤0.01% 2939

Other funds holding VRDN